A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with B cell Lymphoid Malignancies
[Protocol 06-066] |
Barker, Juliet, MBBS |
Transplantation |
A Phase I Study of an mRNA-Modified Dendritic Cell Vaccine in Patients with Melanoma
[Protocol 10-229] |
Young, James, MD |
Melanoma |
A Phase I Study of Clofarabine Plus Topotecan, Vinorelbine, Thiotepa, and Dexamethasone in Pediatric Patients with Relapsed or Refractory Acute Leukemia
[Protocol 07-012] |
Steinherz, Peter, MD |
Acute Lymphoblastic Leukemia Acute Myelocytic Leukemia Acute Myelogenous Leukemia Leukemia |
A Phase I Study of Convection-Enhanced Delivery of 124I-8H9 for Patients with Non-Progressive Diffuse Pontine Gliomas Previously Treated with Radiation Therapy
[Protocol 11-011] |
Souweidane, Mark, MD |
|
A Phase I Study of Donor T Cells Sensitized with Pentadecapeptides of the CMV-PP65 Protein for the Treatment of CMV Infections Following Allogeneic Hematopoietic Stem Cell Transplants
[Protocol 05-065] |
O'Reilly, Richard, MD |
Transplantation |
A Phase I Study of Humanized 3F8 Monoclonal Antibody in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
[Protocol 11-009] |
Basu, Ellen, MD, PhD |
Neuroblastoma |
A Phase I Study of Intraperitoneal Radioimmunotherapy with 131I-8H9 for Patients with Desmoplastic Small Round Cell Tumors and Other Solid Peritoneal Tumors
[Protocol 09-090] |
Modak, Shakeel, MD |
Peritoneal Cancer |
A Phase I Study of Intrathecal Radioimmunotherapy Using 131I-8H9 for Central Nervous System/Leptomeningeal Cancers
[Protocol 03-133] |
Kramer, Kim, MD |
Brain Cancer CNS Cancer Neuroblastoma |
A Phase I Study of Ipilimumab in Children, Adolescents, and Young Adults with Treatment-Refractory Cancer
[Protocol 10-193] |
Wexler, Leonard, MD |
Advanced Cancer Hodgkin's Disease Lymphoma Melanoma Nephroblastoma Non-Hodgkin's Lymphoma Sarcoma Solid Tumors |
A Phase I Study of Modified T Cells Targeted to CD19-Positive Acute Lymphoblastic Leukemia Relapsing After Allogeneic Stem Cell Transplantation
[Protocol 11-038] |
Kernan, Nancy, MD |
Acute Lymphoblastic Leukemia Leukemia |
A Phase I Study of Panitumumab in Children with Solid Tumors
[Protocol 08-020] |
Meyers, Paul, MD |
Solid Tumors |
A Phase I Study of Perifosine with Temsirolimus for Recurrent Pediatric Solid Tumors
[Protocol 09-124] |
Dunkel, Ira, MD |
Solid Tumors |
A Phase I Study of Plerixafor as a Chemosensitizing Agent for Children with Relapsed Acute Leukemia or Myelodysplastic Syndromes
[Protocol 11-208] |
Trippett, Tanya, MD |
Acute Leukemia Acute Lymphoblastic Leukemia Acute Myelogenous Leukemia Leukemia Myelodysplastic Syndrome |
A Phase I Study of Vemurafenib in Adolescents with Inoperable Stage IIIC/IV Melanoma with V600 BRAF Mutations
[Protocol 11-198] |
Pratilas, Christine, MD |
|
A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation
[Protocol 07-055] |
O'Reilly, Richard, MD |
Leukemia Myelodysplastic Syndrome |
A Phase I Trial of NECTAR: Nelarabine, Etoposide, and Cyclophosphamide in Children with T-Cell Acute Lymphoblastic Leukemia
[Protocol 11-119] |
Trippett, Tanya, MD |
Acute Leukemia Acute Lymphoblastic Leukemia Leukemia |
A Phase I/II Clinical Study of Vorinostat Plus Etoposide in Pediatric Patients with Refractory Solid Tumors
[Protocol 10-096] |
Trippett, Tanya, MD |
Advanced Cancer Solid Tumors |
A Phase I/II Study of Brentuximab (SGN-35) in Pediatric Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma or Hodgkin Lymphoma
[Protocol 11-210] |
Trippett, Tanya, MD |
Hodgkin's Disease Lymphoma Non-Hodgkin's Lymphoma |
A Phase I/II Study of the Toxic and Therapeutic Effects of T Cells in the Treatment of Epstein Barr Virus-Associated Lymphoproliferative Disorders
[Protocol 95-024] |
O'Reilly, Richard, MD |
Cancer Leukemia Lymphoma Transplantation |
A Phase I/II Trial of Clofarabine, Melphalan, and Thiotepa Followed by an Allogeneic Stem Cell Transplant for the Treatment of High-Risk and/or Advanced Hematologic Malignancies
[Protocol 06-125] |
Boulad, Farid, MD |
Leukemia Myelodysplastic Syndrome Transplantation |
